0 likes | 6 Views
Bronchial asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties. Symptoms include wheezing, shortness of breath, chest tightness, and persistent cough, often triggered by allergens, respiratory infections, exercise, or irritants. The condition involves intermittent episodes of airway constriction, which can vary in severity. Diagnosis typically involves clinical evaluation and spirometry testing to assess lung function. <br>https://www.pnytrainings.com/
E N D
Group“D” PreparedBy:M.AhmadMansoor PresentedBy:Abu-Baker
BronchialAsthma 01 Tableof Contents Drugs of Bronchial Asthma 02
BronchialAsthma • “BronchialAsthmaisdefinedasaChronicinflammatorydisorderofthe airways which manifests itself as recurrent episodes of wheezing, breathlessness,chesttightnessandcough.” • ItischaracterizedbyBronchialhyper-responsivenessandvariable airflowobstruction.
CausesofAsthma Geneticpredisposition Allergens(e.g.,pollen,dustmites,petdander,mold) Respiratoryinfections Airpollution Occupationalexposuretoirritants Obesity Diet Exercise Coldair
SymptomsofAsthma Shortnessofbreath Chesttightnessorpain Wheezing(awhistlingsoundwhenexhaling) Coughing Troublesleepingduetobreathingproblems
CLASSIFICATION • 1).Atopic/extrinsic/allergic(70%): • Mostcommontype • Environmentalagent:dust,pollen,food,animaldander • Familyhistory- present • SerumIgElevels:Increased • Skintestwithoffendingagent-whealflare • 2).Non-atopic/intrinsic/non-allergic(30%) • Triggered byrespiratorytractinfection • Viruses-mostcommoncause • Familyhistoryuncommon • IgElevelnormal • Noassociatedallergy • SkintestsNEGATIVE • Cause- hyperirritabilityofbronchialtree
CLASSIFICATION • 3).Druginducedasthma • Severalpharmacologicagents • Aspirinsensitiveasthma • Increasedbronchoconstrictor,leukotrienes. • Sensitive tosmall dosesof aspirin. • InhibitsCOXpathway,withoutaffectingLPO pathway.
APPROACHESTOTREATMENT PreventionofAG:ABreaction:Avoidanceofantigen,hyposensitization-possibleinextrinsic asthmaandifantigencanbe identified. Neutralizationof IgE(reaginic antibody): Omalizumab Suppressionofinflammationandbronchialhyperreactivity:Corticosteroids. Preventionofreleaseof mediators:Mastcellstabilizers. Antagonismofreleasedmediators:Leukotrieneantagonists,Antihistamines,PAFantagonists. Blockade of constrictor neurotransmitter:Anticholinergics. Mimickingdilator neurotransmitter:Sympathomimetics. Directlyactingbronchodilators:Methylxanthines.
Drugs • BRONCHODILATORS • B2 Sympathomimetics:Salbutamol,Terbutaline,Bambuterol,Salmeterol,Formoterol. • Methylxanthines:Theophylline(anhydrous), Aminophylline,Cholinetheophyllinate, Hydroxyethyl theophylline,Theophyllineethanolateof piperazine,Doxophylline. • Anticholinergics:Ipratropium bromide, Tiotropium bromide. • LEUKOTRIENEANTAGONISTS • Montelukast,Zafirlukast. • MASTCELLSTABILIZERS • Sodiumcromoglycate,Ketotifen. • CORTICOSTEROIDS • Systemic: Hydrocortisone, Prednisolone andothers. • Inhalational:Beclomethasonedipropionate,Budesonide,Fluticasonepropionate, Flunisolide,Ciclesonide. • ANTI-IgEANTIBODY • Omalizumab
SIDEEFFECTSOFDRUG • Nervousness • Dizziness • Headache • Tremor • Weightgain • Drymouth